What is the current Blood Transfusion Diagnostics Market size?

The Blood Transfusion Diagnostics Market is projected to register a CAGR of 6.90% during the forecast period (2024-2029) Read More

Who are the key players in Blood Transfusion Diagnostics Market?

Grifols, S.A., F. Hoffmann-La Roche Ltd., Diasorin S.p.A, Bio-Rad Laboratories, Inc. and Quotient Suisse SA are the major companies operating in the Blood Transfusion Diagnostics Market. Read More

Which is the fastest growing region in Blood Transfusion Diagnostics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Blood Transfusion Diagnostics Market?

In 2024, the North America accounts for the largest market share in Blood Transfusion Diagnostics Market. Read More

What years does this Blood Transfusion Diagnostics Market cover?

The report covers the Blood Transfusion Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Blood Transfusion Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Blood Transfusion Diagnostics Market Share

Statistics for the 2023 & 2024 Blood Transfusion Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Blood Transfusion Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Blood Transfusion Diagnostics Industry

The Blood Transfusion Diagnostics Market is consolidated in nature. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. The key players in the market include Grifols, S.A., F. Hoffmann-La Roche Ltd., Immucor, Inc., Bio-Rad Laboratories, Inc., Quotient Suisse SA, Merck KGaA, Abbott, Diasorin S.p.A, Danaher, and Werfen among others.